retatrutide clinical trials south africa Representation of racialised and ethnically diverse populations in multicentre randomised controlled of GLP-1 medicines for obesity: a systematic review and meta-analysis of gaps retatrutide clinical trials status 2025

Ideal Candidates You're likely a good candidate if you have BMI of 30+ (obesity) or 27+ with weight-related health conditions, have tried diet and exercise without sustained success, are ready to commit to healthier eating, want medically supervised, FDA-approved treatment, and can invest 6-12 months for optimal results

It functions by mimicking the GLP-1 hormone naturally produced in your body to help control blood sugar levels

GLP-1 medications reduce appetite and significantly lower overall calorie intake, which also reduces your intake and absorption of essential vitamins, minerals and protein

Diabetes Care 41 , 333340 (2018)